Back to mobile site

RBC Cuts Alexza Pharma (ALXA) to Sector Perform, Slashes Price Target to $1.50

October 11, 2010 4:43 PM EDT Send to a Friend
An analyst at RBC Capital has downgraded shares of Alexza Pharma (Nasdaq: ALXA) from Outperform to Sector Perform this ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login